Development of a knowledge assessment tool for dermatotoxicity caused by inhibitors of epidermal growth factor receptor.

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol (2004) 9.73

Determination and quantification of content validity. Nurs Res (1986) 8.60

EGFR and cancer prognosis. Eur J Cancer (2001) 7.52

The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res (2006) 3.17

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol (2007) 1.47

Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial. J Clin Oncol (2009) 1.40

Anti-epidermal growth factor receptor drugs in cancer therapy. Expert Opin Investig Drugs (2002) 1.08

Cetuximab (Erbitux)--an emerging targeted therapy for epidermal growth factor receptor-expressing tumours. Int J Clin Pract (2004) 0.88

Panitumumab in colon cancer: a review and summary of ongoing trials. Expert Opin Biol Ther (2006) 0.84

Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke (2010) 2.69

Primary aldosteronism in hypertensive patients: clinical implications and target therapy. Eur J Clin Invest (2014) 1.99

Pancreatic insulinoma: current issues and trends. Hepatobiliary Pancreat Dis Int (2010) 1.19

Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol (2014) 1.05

Laparoscopic resection of large adrenal tumors. JSLS (2011) 0.89

Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension. J Clin Endocrinol Metab (2013) 0.85

The functional status of incidentally discovered bilateral adrenal lesions. Clin Endocrinol (Oxf) (2011) 0.80

A novel mechanism of inherited TBG deficiency: mutation in a liver-specific enhancer. J Clin Endocrinol Metab (2015) 0.79

Primary pigmented nodular adrenocortical disease presenting with a unilateral adrenocortical nodule treated with bilateral laparoscopic adrenalectomy: a case report. J Med Case Rep (2010) 0.78

A European survey of oncology nurse breakthrough cancer pain practices. Eur J Oncol Nurs (2012) 0.78

Hemodynamic markers and subclinical atherosclerosis in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab (2014) 0.77

How nurses assess breakthrough cancer pain, and the impact of this pain on patients' daily lives--results of a European survey. Eur J Oncol Nurs (2012) 0.76

Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. Eur J Clin Invest (2012) 0.75

Monitoring of Frequency and Antimicrobial Susceptibility of Pathogens on the Hands of Healthcare Workers in a Tertiary Hospital. Folia Med (Plovdiv) (2016) 0.75

Case report: Primary pituitary non-Hodgkin's lymphoma developed following surgery and radiation of a pituitary macroadenoma. Hormones (Athens) (2013) 0.75